Abstract
Full text available
Current Drug Safety
Title: Opinion: [Withdrawal of Rimonabant – Walking the Tightrope of 21st Century Pharmaceutical Regulation?]
Volume: 4 Issue: 1
Author(s): David Taylor
Affiliation:
Abstract: Full text available
Export Options
About this article
Cite this article as:
Taylor David, Opinion: [Withdrawal of Rimonabant – Walking the Tightrope of 21st Century Pharmaceutical Regulation?], Current Drug Safety 2009; 4 (1) . https://dx.doi.org/10.2174/157488609787354396
DOI https://dx.doi.org/10.2174/157488609787354396 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patient Involvement and Shared Decision-Making in Mental Health Care
Current Clinical Pharmacology Kinase Phosphorylation-based Mechanisms of PARP Inhibitor Resistance During Synthetic Lethal Oncotherapy
Current Signal Transduction Therapy Editorial [Hot Topic: Alzheimers Disease: Highlights from Research on Hormones, Growth Factors and Signaling Pathways (Debomoy K. Lahiri)]
Current Alzheimer Research The Antagonists of Endothelin Receptors: Results and Perspectives
Current Pharmaceutical Analysis Fibrinogen Signal Transduction as a Mediator and Therapeutic Target in Inflammation:Lessons from Multiple Sclerosis
Current Medicinal Chemistry Mammalian Cytosolic Glutathione Transferases
Current Protein & Peptide Science Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer’s Disease
Medicinal Chemistry Retromer's Role in Endosomal Trafficking and Impaired Function in Neurodegenerative Diseases
Current Protein & Peptide Science Are the Myokines the Mediators of Physical Activity-Induced Health Benefits?
Current Pharmaceutical Design Enhanced Selectivity Screening of GPCR Ligands Using a Label-Free Cell Based Assay Technology
Combinatorial Chemistry & High Throughput Screening Cell Therapy for Inner Ear Diseases
Current Pharmaceutical Design Diversity Oriented p-TSA Catalyzed Efficient and Environmentally Benign Synthetic Protocol for the Synthesis of Structurally Diverse Heteroannulated Benzothiazolopyrimidines
Current Organocatalysis A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies
Mini-Reviews in Medicinal Chemistry Features and Factors Associated with Drinking Problems or Illegal Drugs Use: A Cross Sectional Cohort Study with Patients of a Psychosocial Care Service
Applied Clinical Research, Clinical Trials and Regulatory Affairs Effects of Synthetic Peptides on the Inflammatory Response and their Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Beyond the Synapse and Hebb's Rule: Is the Rest of the Neuron More Important for Psychiatric Disorders?
Current Psychiatry Reviews Recent Updates of Chemically Modified Electrodes in Pharmaceutical Analysis
Combinatorial Chemistry & High Throughput Screening Peptides as Modulators of α-Synuclein Aggregation
Protein & Peptide Letters Membrane Pathology in Schizophrenia: Implication for Arachidonic Acid Signaling
Current Medicinal Chemistry - Central Nervous System Agents Principles and Applications of Diffuse Optical Imaging for the Brain
Current Medical Imaging